Pilot clinical protocols
The Queensland community pharmacy clinical protocols have been updated effective 7 April 2026. Pharmacists should familiarise themselves with the revised protocols and ensure that they are using the most current versions.
A summary of changes for the chronic conditions clinical protocols (PDF 247 kB) is available to support pharmacists in understanding the key updates to these documents.
| Indication | Guideline/protocol |
|---|---|
| Chronic obstructive pulmonary disease (COPD) | Chronic Obstructive Pulmonary Disease (COPD) Monitoring Program clinical protocol (PDF 682 kB) |
| Cardiovascular disease risk reduction: hypertension | Cardiovascular Disease (CVD) Risk Reduction Program – CVD risk assessment and hypertension management clinical protocol (PDF 656 kB) |
| Cardiovascular disease risk reduction: blood glucose management | Cardiovascular Disease (CVD) Risk Reduction Program – blood glucose management clinical protocol (PDF 595 kB) |
| Cardiovascular disease risk reduction: lipid modification | Cardiovascular Disease (CVD) Risk Reduction Program – lipid modification clinical protocol (PDF 594 kB) |
| Asthma | Improved Asthma Symptom Control Program clinical protocol (PDF 636 kB) |